Pharmacology & Physiology
Chiara Manzini, PhD, received more than $2 million to study molecular mechanisms of male bias in autism.
Nikki Posnack, PhD, assistant professor of pediatrics and of pharmacology and physiology, spoke to Chemical Watch for an article discussing her recent study that showed BPA can adversely affect adult heart function.
Henry J. Kaminski, MD, chair of the Department of Neurology and Meta Amalia Neumann Professor of Neurology and Linda Kusner, PhD, associate professor of pharmacology and physiology, serve as co-editors of the newly published third edition of the reference book, “Myasthenia Gravis and Related…
The National Institutes of Health recently awarded more than $2.4 million to a research team at the GW School of Medicine and Health Sciences, to study how cell stress in the brain could impact the risk of obesity-induced hypertension.
Kevin Pelphrey, PhD, director of the Autism and Neurodevelopmental Disorders Institute and professor of pharmacology & physiology, authored an article for Spectrum about what teenagers can teach scientists about autism.
Paul Marvar, PhD, at GW School of Medicine and Health Sciences, received a large grant from the NIH to study a possible link between post-traumatic stress disorder and cardiovascular disease.
Leo Chalupa, PhD, vice president for research and professor of pharmacology and physiology, authored an op-ed for The Hill discussing the status of neuroscience in the U.S. and how it can progress.
Vittorio Gallo, PhD, associate dean of child health research and professor of pediatrics and of pharmacology and physiology, was quoted by the Daily Mail (United Kingdom) in article discussing his research on how parents can facilitate earlier cognitive development in their children.
Kevin Pelphrey, PhD, director of the Autism and Neurodevelopmental Disorders Institute and professor of pharmacology and physiology, spoke to NPR for an article discussing underdiagnosis of autism in girls.
Norman Lee, PhD, professor of pharmacology and physiology, published research in Nature Communications finding that a form of genetic variation, called differential RNA splicing, may have a role in tumor aggressiveness and drug resistance in African American men with prostate cancer.